BLOOD COAGULATION PROBLEMS AND THROMBOEMBOLIC COMPLICATIONS IN THE ACUTE STAGE OF STROKE

Cover Page


Cite item

Full Text

Abstract

Background: High prevalence of stroke and constant mortality which is related to thromboembolic complications in one fourth of patients make it necessary to continue evaluation of clinically precise and technologically feasible methods of adequate control of coagulation and anticoagulation systems and predicting of venous thromboses and embolism. Aim: To improve diagnostics and treatment of patients with acute stroke of various types through assessment of haemostasis system and pathophysiological mechanisms of venous thromboembolism (VTE). Materials and methods: One hundred and forty five (145) patients with acute cerebral stroke (mean age, 69±13.2 years; 75 male and 70  female) were included into the study. All patients were admitted to the neuroresuscitation unit within 6 to 24 hours from manifestation; the diagnosis was verified by multiaxial computerized tomography. One hundred and four (104) (71.7%) of patients had ischemic stroke, 41 (28.3%) of patients had hemorrhagic stroke. At admittance, all patients had a  certain level of consciousness derangement. All patients were monitored by means of computerized tomography, general and neurological assessment, functional assessment, chest X-ray, ultrasound examination of extremities and assessment of haemostasis (screening and direct thrombodynamics test). Results: In 95%  of cases, VTE risk factors were found; VTE developed in 40  (27.6%) of patients. The most frequent complication was pulmonary embolism (90%  of all VTE and 24.8%  of 145  patients). In-hospital mortality was 44.1%  (n=64) and correlated with VTE (r=0.384; р<0.01). Outcomes of ischemic stroke depended mainly on VTE (at autopsy, they were found in 58.5%  of patients with ischemic stroke and in 26.1%  of those with hemorrhagic stroke) and other complications. Outcomes of hemorrhagic insult depended on the size of the lesion that correlated with severity of clinical symptoms. Screening coagulation parameters were not informative enough for the assessment of haemostasis. Development of VTE correlated with some hypercoagulation in the first days after stroke that were quickly transformed into hypocoagulation. This process could be reliably assessed by the thrombodynamics test. Conclusion: Taking into account high incidence of VTE in patients with severe stroke and low informative value of coagulation screening, it is reasonable to use direct methods of haemostasis assessment and individualized approached to preventive and therapeutic anticoagulation.

About the authors

E. V. Silina

I.M. Sechenov First Moscow State Medical University

Author for correspondence.
Email: silinaekaterina@mail.ru

MD, PhD, Professor, Chair of Human Pathology, Institute for Professional Education

9/10–339 prospekt Vernadskogo, Moscow, 119311

Tel.: +7 (916) 710 12 65

8/2 Trubetskaya ul., Moscow, 119991

Russian Federation

S. A. Rumyantseva

N.I. Pirogov Russian National Research Medical University

Email: fake@neicon.ru

MD, PhD, Professor, Chair of Neurology, Postgraduate Training Faculty 

1 Ostrovityanova ul., Moscow, 117997

Russian Federation

E. N. Kabaeva

I.M. Sechenov First Moscow State Medical University

Email: fake@neicon.ru

Postgraduate Student, Chair of Human Pathology, Institute for Professional Education

8/2 Trubetskaya ul., Moscow, 119991

Russian Federation

V. A. Stupin

N.I. Pirogov Russian National Research Medical University

Email: fake@neicon.ru

Head of Department of Hospital Surgery No. 1, Мedical Faculty 

1 Ostrovityanova ul., Moscow, 117997

Russian Federation

References

  1. Беленков ЮН, Оганов РГ, ред. Кардиология. Национальное руководство. М.: ГЭОТАР-Медиа; 2010. 1232 с.
  2. Оганов РГ, Тимофеева ТН, Колтунов ИЕ, Константинов ВВ, Баланова ЮА, Капустина АВ, Лельчук ИН, Шальнова СА, Деев АД. Эпидемиология артериальной гипертонии в России. Результаты федерального мониторинга 2003–2010 гг. Кардиоваскулярная терапия и профилактика. 2011;10(1):9–13.
  3. Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR, Sacks FM, Smith SC Jr, Vafiadis DK, Van Horn LV. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation. 2011;123(10):1138– 43. doi: 10.1161/CIR.0b013e31820d0793.
  4. Grenfell R, Lee R, Stavreski B, Page K. The hidden epidemic of hypertension. Heart Lung Circ. 2014;23(4):381–2. doi: 10.1016/j. hlc.2013.11.013.
  5. Румянцева СА, Силина ЕВ, Свищева СП, Комаров АН. Медицинские и организационные проблемы до- и постинсультной инвалидизации. Журнал неврологии и психиатрии им. С.С. Корсакова. 2013;111(9–2): 43–9.
  6. Скорикова ЮС, Аристархова ОЮ. Инфаркт/ инсульт: зеркальное отражение или искаженное зеркало. Врач скорой помощи. 2009;(3):47–51.
  7. Стаховская ЛВ, Клочихина ОА, Богатырева МД, Коваленко ВВ. Эпидемиология инсульта в России по результатам территориально-популяционного регистра (2009–2010). Журнал неврологии и психиатрии им. С.С. Корсакова. 2013;113(5):4–10.
  8. Стародубцева ОС, Бегичева СВ. Анализ заболеваемости инсультом с использованием информационных технологий. Фундаментальные исследования. 2012;(8–2):424–7.
  9. Румянцева СА, Ступин ВА, Афанасьев ВВ, Федин АИ, Силина ЕВ. Критические состояния в клинической практике. М.: Медицинская книга; 2011. 732 с.
  10. Рябинкина ЮВ, Гнедовская ЕВ, Пирадов МА, Кунцевич ГИ. Профилактика венозных тромбоэмболических осложнений у больных с тяжелым инсультом. Журнал неврологии и психиатрии им. С.С. Корсакова. 2010;110(9–2):18–23.
  11. Фонякин АВ, Гераскина ЛА. Факторы риска, диагностика, лечение и профилактика венозных тромбозов и тромбоэмболий при остром инсульте. Неврология, нейропсихиатрия, психосоматика. 2013;(4):4–9.
  12. Condliffe R, Elliot CA, Hughes RJ, Hurdman J, Maclean RM, Sabroe I, van Veen JJ, Kiely DG. Management dilemmas in acute pulmonary embolism. Thorax. 2014;69(2):174–80. doi: 10.1136/thoraxjnl-2013-204667.
  13. Turpie AG, Hull RD, Schellong SM, Tapson VF, Monreal M, Samama MM, Chen M, Yusen RD; EXCLAIM Investigators. Venous thromboembolism risk in ischemic stroke patients receiving extended-duration enoxaparin prophylaxis: results from the EXCLAIM study. Stroke. 2013;44(1):249–51. doi: 10.1161/STROKEAHA.112.659797.
  14. Савельев ВС, Чазов ЕИ, Гусев ЕИ, Кири- енко АИ, Акчурин РС, Андрияшкин ВВ, Арутюнов ГП, Бицадзе ВО, Бодыхов МК, Бритов АН, Бутенко АВ, Вавилова ТВ, Войновский ЕА, Воробьева НА, Восканян ЮЭ, Гавриленко АВ, Галстян ГМ, Гельфанд БР, Голубев ГШ, Замятин МН, Затевахин ИИ, Золкин ВН, Золотухин ИА, Кобалава ЖД, Копенкин СС, Кузнецов НА, Кунцевич ГИ, Леонтьев СГ, Лубнин АЮ, Макацария АД, Моисеев ВС, Момот АП, Осипова НА, Острякова ЕВ, Панченко ЕП, Переходов СН, Пи- радов МА, Поддубная ИВ, Покровский АВ, Прудков МИ, Прядко СИ, Решетняк ТМ, Рябинкина ЮВ, Сапелкин СВ, Семенова МН, Смирнов СВ, Соколов ВА, Стаховская ЛВ, Терещенко СН, Стойко ЮМ, Сулимов ВА, Фокин АА, Шевела АИ, Шиманко АИ, Шулутко АМ, Явелов ИС, Яхонтов ДИ. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений. Флебология. 2010;4(2–1):2–37.
  15. Mahan CE. Regulatory, policy and quality update for venous thromboembolism and stroke in United States hospitals. Thromb Res. 2012;130(4):586–90. doi: 10.1016/j. thromres.2012.07.001.
  16. Бокарев ИН, Попова ЛВ. Венозный тромбо-эмболизм и тромбоэмболия легочной артерии. М.: МИА; 2005. 208 с.
  17. Skaf E, Stein PD, Beemath A, Sanchez J, Bustamante MA, Olson RE. Venous thromboembolism in patients with ischemic and hemorrhagic stroke. Am J Cardiol. 2005;96(12):1731–3. doi: 10.1016/j. amjcard.2005.07.097.
  18. Sostman HD, Miniati M, Gottschalk A, Matta F, Stein PD, Pistolesi M. Sensitivity and specificity of perfusion scintigraphy combined with chest radiography for acute pulmonary embolism in PIOPED II. J Nucl Med. 2008;49(11):1741–8. doi: 10.2967/jnumed.108.052217.
  19. Soshitova NP, Karamzin SS, Balandina AN, Fadeeva OA, Kretchetova AV, Galstian GM, Panteleev MA, Ataullakhanov FI. Predicting prothrombotic tendencies in sepsis using spatial clot growth dynamics. Blood Coagul Fibrinolysis. 2012;23(6):498–507. doi: 10.1097/ MBC.0b013e328352e90e.
  20. Dashkevich NM, Vuimo TA, Ovsepyan RA, Surov SS, Soshitova NP, Panteleev MA, Ataullakhanov F, Negrier C. Effect of preanalytical conditions on the thrombodynamics assay. Thromb Res. 2014;133(3):472–6. doi: 10.1016/j.thromres.2013.12.014

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Silina E.V., Rumyantseva S.A., Kabaeva E.N., Stupin V.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies